[Why D-galacturonic acid does not bind agglutinin from Ricinis communis]
Related Experiment Video
Updated: Nov 7, 2026

Rapid Glyco-Qualitative Assessment of Recombinant Proteins Using a Fully Automated System
Published on: June 28, 2024
1Department of Biological Chemistry, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.
Abstract:
Binding of various C6 galactose derivatives to Ricinus communis agglutinin (RCA I) was studied in order to better understand the structural elements involved in lectin-sugar interactions. The inability of D-galacturonic acid to inhibit the hemagglutination of red blood cells by RCA I, at low concentrations, is shown to be due to intramolecular hydrogen bonding between the hydrogen atom of the C4 hydroxyl group and one of the oxygen atoms of the carboxylate anion of D-galacturonic acid and not to the negative charge and/or the steric size of the C6 carboxylate as previously suggested. Thus it is unequivocally shown that during the binding of D-galactose to RCA I, the C4 hydroxyl group of D-galactose serves as the hydrogen bond donor. It is also shown that a negatively charged substituent at the C6 atom of D-galactose, as in D-galactose-6-sulfate, does not inhibit the binding of the modified D-galactose molecule to RCA I, whereas a positively charged group, as in protonated 6-amino-6-deoxy-D-galactose, dramatically inhibits the binding.
More Related Videos
Related Concept Videos
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Rh Blood Group
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

